Management of toxic epidermal necrolysis and related syndromes.
Toxic epidermal necrolysis and Stevens-Johnson syndrome are rare and life-threatening diseases that often configure as medical emergencies. The majority of cases are drug reactions. The clinical picture is one of widespread epidermal necrosis and mucosal erosions. Treatment is largely supportive and must be provided in an appropriate environment. The role of steroids and other potential disease-modifying therapies has yet to be fully established by controlled studies. The significant mortality associated with these conditions dictates that an understanding of these conditions is essential for all doctors.
Mukasa
Y
Y
Department of Dermatology, Macclesfield District General Hospital, Macclesfield, Cheshire, UK.
Craven
N
N
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010956:Plasmapheresis; D011379:Prognosis; D006435:Renal Dialysis; D018805:Sepsis / Q000517:prevention & control; D013256:Steroids / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D013256:Steroids